文献速递角膜与眼表疾病

角膜内皮/后弹力膜复合体的在体特征用于诊断角膜移植排斥反应

In Vivo Characteristics of Corneal Endothelium/Descemet Membrane Complex for the Diagnosis of Corneal Graft Rejection.
PubMed 文献 · Am J Ophthalmol · 2017-03-02

该诊断可靠性研究对139只眼(含96只角膜移植术后眼及43只年龄匹配对照眼)行高清光学相干断层扫描,测量中央角膜厚度(CCT)和中央内皮/后弹力膜厚度(DMT)并计算内皮/后弹力膜排斥指数(DRI)。结果显示活动性排斥移植眼的DMT和DRI显著大于对照和透明移植眼,排斥移植眼DMT和DRI最高,DMT和DRI在区分各组时准确性优于CCT,且DMT与排斥严重程度显著相关。

要点

  • 活动性排斥移植眼DMT为28 μm、DRI为1.5,显著大于对照眼和透明移植眼(均P < .001)。
  • 排斥移植眼DMT为59 μm、DRI为2.1,为所有组中最高(P < .001)。
  • DMT和DRI区分活动性排斥与透明移植的灵敏度为100%和96%,特异度均为92.5%,准确性优于CCT。

核心结论

  • 在角膜移植眼中,内皮/后弹力膜相对增厚可诊断移植排斥反应,以DMT和DRI衡量。
  • DMT和DRI在检测移植免疫状态方面准确性、灵敏度和特异度均优,优于CCT。
  • DMT是与排斥严重程度准确相关的定量指标(P < .001)。

研究设计与样本

  • 诊断可靠性研究,纳入139只眼,包括96只穿透性角膜移植或后弹力膜剥除自动内皮角膜移植术后眼(40只透明、23只活动性排斥、24只排斥、9只非免疫性失败)及43只年龄匹配对照眼。
  • 采用高清光学相干断层扫描成像,描述内皮/后弹力膜复合体并测量中央角膜厚度(CCT)和中央内皮/后弹力膜厚度(DMT),计算内皮/后弹力膜排斥指数(DRI)。

主要发现

  • 活动性排斥移植眼DMT为28 μm、DRI为1.5,显著大于对照眼和透明移植眼(分别为17 μm和1,均P < .001)。
  • 排斥移植眼DMT为59 μm、DRI为2.1,为所有组中最高(P < .001)。
  • DMT和DRI区分活动性排斥与透明移植的灵敏度为100%和96%,特异度均为92.5%。
  • DMT和DRI区分活动性排斥与排斥移植的灵敏度为88%和83%,特异度为91%和83%。
  • DMT和DRI区分非免疫性失败与排斥移植的灵敏度均为100%,特异度为88%和100%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the utility of endothelial/Descemet membrane complex (En/DM) characteristics in diagnosing corneal graft rejection. DESIGN: Diagnostic reliability study. METHODS: One hundred thirty-nine eyes (96 corneal grafts post penetrating keratoplasty or Descemet stripping automated endothelial keratoplasty: 40 clear, 23 actively rejecting, 24 rejected, and 9 nonimmunologic failed grafts; along with 43 age-matched control eyes) were imaged using high-definition optical coherence tomography. Images were used to describe En/DM and measure central corneal thickness (CCT) and central En/DM thickness (DMT). En/DM rejection index (DRI) was computed to detect the relative En/DM thickening to the entire cornea. RESULTS: In actively rejecting grafts, DMT and DRI were significantly greater than controls and clear grafts (28, 17, and 17 μm and 1.5, 1 and 1, respectively; P < .001). Rejected grafts had the highest DMT and DRI compared to all groups (59 μm and 2.1; P < .001). DMT and DRI showed excellent accuracy, significantly better than that of CCT, in differentiating actively rejecting from clear grafts (100% and 96% sensitivity; 92.5% and 92.5% specificity), actively rejecting from rejected grafts (88% and 83% sensitivity; 91% and 83% specificity), and nonimmunologic failed from rejected grafts (100% and 100% sensitivity; 88% and 100% specificity). DMT correlated significantly with rejection severity (P < .001). CONCLUSIONS: In corneal grafts, in vivo relative thickening of the En/DM is diagnostic of graft rejection as measured by DMT and DRI. These indices have excellent accuracy, sensitivity, and specificity in detecting graft immunologic status, superior to CCT. DMT is a quantitative index that correlates accurately with the severity of rejection.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Abou Shousha M, Yoo SH, Sayed MS, et al. In Vivo Characteristics of Corneal Endothelium/Descemet Membrane Complex for the Diagnosis of Corneal Graft Rejection. Am J Ophthalmol. 2017. PMID: 28259779. doi:10.1016/j.ajo.2017.02.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。